| 000 | 01467 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250515001143.0 | ||
| 264 | 0 | _c20051027 | |
| 008 | 200510s 0 0 eng d | ||
| 022 | _a0001-2998 | ||
| 024 | 7 |
_a10.1053/j.semnuclmed.2005.05.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMenda, Yusuf | |
| 245 | 0 | 0 |
_aUpdate on 18F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers. _h[electronic resource] |
| 260 |
_bSeminars in nuclear medicine _cOct 2005 |
||
| 300 |
_a214-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdiagnostic imaging |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aFluorodeoxyglucose F18 |
| 650 | 0 | 4 |
_aHead and Neck Neoplasms _xdiagnostic imaging |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPositron-Emission Tomography _xmethods |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 | _aPractice Patterns, Physicians' |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRadiopharmaceuticals |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aSubtraction Technique |
| 650 | 0 | 4 |
_aTomography, X-Ray Computed _xmethods |
| 700 | 1 | _aGraham, Michael M | |
| 773 | 0 |
_tSeminars in nuclear medicine _gvol. 35 _gno. 4 _gp. 214-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1053/j.semnuclmed.2005.05.001 _zAvailable from publisher's website |
| 999 |
_c15784704 _d15784704 |
||